Skip to main content
Caplight Logo









ADNTRO GENETICS

ADNTRO GENETICS

Private
PalmaHealthcare & Life Scienceshttps://adntro.com/en/

Last Round

Seed

Oct 4, 2024

Total Funding Raised

$1.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ADNTRO GENETICS is a biotechnology company that provides direct-to-consumer DNA testing kits and bioinformatics analysis for insights into ancestry, health, nutrition, and sports performance.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics

Business Model

B2C

Customer Profile

Hardware + Subscription, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

genetic testingDNA analysispersonalized genomicsbioinformaticspolygenic risk scorePRSdirect-to-consumer DNADTC geneticspharmacogeneticsprecision medicinegenetic counselinggenomic dataAI health assistanthealth techbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ADNTRO GENETICS Comparables

Compare ADNTRO GENETICS with similar companies based on industry and business-model similarity.

ADNTRO GENETICS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
24Genetics
89%
tellmeGen
86%
SelfDecode
83%

ADNTRO GENETICS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 4, 2024
AcceleratorDec 1, 2021

Key People

Founding team and executive leadership

Jorge Blom-Dahl Oliver

CTO And Cofounder

Founding Team

Guillermo Pérez-Solero Monzon

CEO Founder

Founding Team

ADNTRO GENETICS Investors

Notable investors and investment history

ADNTRO GENETICS investors
InvestorRounds
LanzaderaAccelerator, Seed
Noso CapitalSeed
Addendum CapitalSeed
Blue Goose CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 32% MoM.

  • Oct 4, 2024

    $1.1M round led by biotechsmartcapital and Noso Capital

ADNTRO GENETICS Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ADNTRO GENETICS Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ADNTRO GENETICS's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalma
Employee Range16
Year Founded2019
Last FundingOct 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?